Ken Song has done it again.
The biopharma veteran’s all-out effort to prove T cell engagers’ potential in autoimmune diseases is getting picked up by …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
